Stellar Biotechnologies produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and KLH subunit formulations in the United States and Europe. The company’s KLH is an immunogenic high-molecular-weight protein, which is used in cancer and therapeutic vaccines for lymphoma, bladder, breast, colon, sarcoma, small cell lung cancer, Alzheimer’s disease, rheumatoid arthritis, lupus and post-traumatic stress disorder chemical dependencies. For further information, visit the company’s Web site www.stellarbiotechnologies.com

EBD Group’s Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place during the course of one of the industry’s largest annual healthcare investor conferences. Investors and biopharmaceutical executives from around the world gather in San Francisco for this important event.

Let us hear your thoughts below: